A cancer vaccine that can cure 97% of mouse tumors has been approved for human trials, the report said

Recently, US media reported that a cancer vaccine that can cure 97% of mouse tumors has been approved for human trials (http:// Dr Ronald levy, a professor of oncology and chief researcher of scientific translational medicine at Stanford University, and his research team found that the new vaccine eliminated 87 of the tumors in the body, even if the tumor spread to other parts of the body of the mouse, the cure rate of the tumor reached 9 7% Dr Levy said that unlike traditional vaccines, which play a sustained immune role, the new vaccines tend to be an immunotherapy, the main mechanism of which is to attack cancer cells with the human autoimmune system The new vaccine involves two drugs (http:// that stimulate T cells (an immune cell) When injected into the body, the two drugs work together to activate T cells and then eliminate tumors Animal experiments show that these activated T cells can destroy the whole body tumor and prevent the growth of cancer cells At present, the human trial of the new vaccine will be launched at the end of the year, focusing on lymphoma, involving about 35 patients